SBIR/STTR Research Award

Novel Single Cell Assay to Identify Genes Underlying Developmental Neurotoxicity

Award identifier 2171a8ba4860c0c509b72503f51115f0e12b8213e0d5cfaead959a295f3e6ee1Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,909

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PREDICTIVE BIOLOGY
Proposal award date
2017-08-01
Contract end date
2019-07-31
UEI
F1PNSXJZC269
Solicitation number
PA16-302
Topic code
113

Research abstract

Abstract Traditional tests for developmental neurotoxicity have involved animal studies with behavioral or anatomical readouts that are integrative of toxicant effects on the whole organism However they are not informative of mechanism of action particularly with molecular detail Recently methods to produce D brain organoids from stem cells were developed These cortical organoids exhibit much more of the spatial and cell type organization of authentic cortical regions of the developing brain We propose to develop a novel genetic screen of neurotoxicant effects on brain organoid development The proposed project brings together several established as well as recent emerging technologies with a novel panel of over genetically diverse ES cell lines to solve a problem that has been a barrier to developmental neurotoxicity DNT testing Bulk harvesting of RNA required that expression studies use uniform cell populations However neurodevelopment is an inherently cell heterogenous process In this project we will use brain organoids produced in vitro from panel of genetically diverse ES cell lines in combination with single cell RNAseq to develop a scalable highly efficient and highly granular eQTL DNT screen The key innovations of our technology is combining complex trait genetics with single cell transcriptomes and defining subpopulations of differentiating neural cell types using single cell transcriptomes then assigning individual genetically diverse cells to the appropriate subpopulation In this way the muddle of data from heterogenous cell mixtures is avoided !The developing brain is highly vulnerable to chemicals that can cause damage to nervous system cell growth function and development We are creating a new test to understand that damage in deep molecular detail in individual cells of a minibrain model !

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2007–2020). Reported award amounts total $7,478,355. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.